Sanofi did combine lixisenatide with insulin glargine in a premixed pen (Soliqua), which was a novel combo product for patients needing both basal insulin and a GLP-1 RA
Some possible peptide therapy side effects include: Hives, swelling, or breathing difficulty High blood pressure, rapid heart rate, and palpitations Nausea, vomiting, and diarrhea Headaches and dizziness Rashes Always consult a doctor before starting peptide therapy
These observations suggest that G-POEM may have a place in the management of individuals with refractory symptomatic gastroparesis [80]
This should also include any vitamins, supplements, or herbal products
Rarer-yet-serious GLP-1 risks While rarer than the above side effects, there are some serious issues that could arise if youre taking a GLP-1